Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 9.48
+0.43 (4.80%)
Apr 8, 2026, 9:25 AM CET
Grifols Revenue
In the year 2025, Grifols had annual revenue of 7.52B EUR with 4.33% growth. Grifols had revenue of 1.98B in the quarter ending December 31, 2025, with 0.32% growth.
Revenue
7.52B
Revenue Growth
+4.33%
P/S Ratio
0.75
Revenue / Employee
297.89K
Employees
25,258
Market Cap
5.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.52B | 312.00M | 4.33% |
| Dec 31, 2024 | 7.21B | 620.00M | 9.41% |
| Dec 31, 2023 | 6.59B | 528.03M | 8.71% |
| Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Faes Farma | 626.99M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 253.56M |
| Pharma Mar | 221.39M |
| Atrys Health | 145.00M |
Grifols News
- 8 days ago - Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates - GlobeNewsWire
- 14 days ago - Grifols approves IPO of its US biopharma business - Reuters
- 21 days ago - Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease - GlobeNewsWire
- 25 days ago - Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance - GlobeNewsWire
- 26 days ago - Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites - GlobeNewsWire
- 5 weeks ago - Grifols doubles net profit in 2025, driven by revenues - Reuters
- 6 months ago - Spanish court summons Gotham City founder in Grifols share price probe - Reuters
- 10 months ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire